New study probes why some babies develop eczema: Self-Antibodies under the microscope
NCT ID NCT07316465
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether babies born with certain self-reactive antibodies are more likely to develop eczema. Researchers will test umbilical cord blood from 500 newborns—some with a family history of allergies or eczema, some without—and follow them for two years. The goal is to understand when and why these antibodies appear and if they can predict eczema.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB)
RECRUITINGJette, Brussels Capital, 1090, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ozonated oil soothe eczema in kids?
- Can a Skin-Repairing cream soothe eczema?
- Can a new antibody calm severe eczema?
- Microscopic skin scans may reveal how a new eczema drug reshapes the skin
- Can filtering the blood slow ALS in people with a troubling antibody?
- Baby's first pose: could lying prone or on its side during cord clamping boost vital signs?